← Back to Search

Diagnostic Test

Treatment for Bladder Cancer

N/A
Recruiting
Led By Hideki Furuya, PhD
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

University of Texas, Southwestern Medical Center at DallasOTHER
17 Previous Clinical Trials
20,315 Total Patients Enrolled
Cedars-Sinai Medical CenterLead Sponsor
509 Previous Clinical Trials
165,013 Total Patients Enrolled
Nara Prefecture Seiwa Medical CenterUNKNOWN
1 Previous Clinical Trials
450 Total Patients Enrolled
~125 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top